COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION
申请人:Cleave Biosciences, Inc.
公开号:US20140235548A1
公开(公告)日:2014-08-21
Compounds, pharmaceutical compositions, and methods of using such compounds to treat or prevent diseases or disorders associated with or mediated by JAMM proteins are disclosed. The compounds and compositions inhibit the enzymatic activity of a JAMM domain, including the JAMM domain of the CSN5 subunit of the COP9-signalsome (CSN), the JAMM domain of the Rpn11/Poh1/Psmd14 subunit of the 26S proteasome, the JAMM domain of AMSH, the JAMM domain of AMSH-LP, the JAMM domain of BRCC36, among other JAMM domains.
[EN] COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION<br/>[FR] COMPOSITION ET PROCÉDÉS POUR L'INHIBITION DES PROTÉINES JAMM
申请人:ZHOU HAN-JIE
公开号:WO2012158435A1
公开(公告)日:2012-11-22
Compounds, pharmaceutical compositions, and methods of using such compounds to treat or prevent diseases or disorders associated with or mediated by JAMM proteins are disclosed. The compounds and compositions inhibit the enzymatic activity of a JAMM domain, including the JAMM domain of the CSN5 subunit of the COP9-signalsome (CSN), the JAMM domain of the Rpn11/Poh1/Psmd14 subunit of the 26S proteasome, the JAMM domain of AMSH, the JAMM domain of AMSH-LP, the JAMM domain of BRCC36, among other JAMM domains.
[EN] COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION<br/>[FR] COMPOSITIONS ET MÉTHODES D'INHIBITION DES PROTÉINES JAMM
申请人:CLEAVE BIOSCIENCES INC
公开号:WO2014066506A2
公开(公告)日:2014-05-01
Compounds, pharmaceutical compositions, and methods of using such compounds to treat or prevent diseases or disorders associated with or mediated by JAMM proteins are disclosed.
Development of Ubiquitin‐Based Probe for Metalloprotease Deubiquitinases
作者:Dharjath S. Hameed、Aysegul Sapmaz、Lindsey Burggraaff、Alessia Amore、Cornelis J. Slingerland、Gerard J. P. Westen、Huib Ovaa
DOI:10.1002/anie.201906790
日期:2019.10.7
probes. Described here is a Ub-based probe that contains a ubiquitin moiety modified at its C-terminus with a Zn2+ chelating group based on 8-mercaptoquinoline, and a modification at the N-terminus with either a fluorescent tag or a pull-down tag. The probe is validated using Rpn11, a metalloDUB found in the 26S proteasome complex. This probe binds to metalloDUBs and efficiently pulled down overexpressed